Serina Therapeutics's total assets for Q2 2025 were $8.94M, an increase of 32.83% from the previous quarter. SER total liabilities were $7.29M for the fiscal quarter, a 41.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.